BCM
EVLV icon

Bayesian Capital Management’s Evolv Technologies EVLV Stock Holding History

Bayesian Capital Management’s Portfolio EVLV Stock Details EVLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,700
Closed -$149K – 261
2025
Q3 		$149K Sell
19,700
-1,300
-6% -$9.49K 0.03% 477
2025
Q2 		$131K Buy
+21,000
New +$97.2K 0.02% 486
2023
Q1 		– Sell
-36,153
Closed -$93.6K – 887
2022
Q4 		$93.6K Buy
+36,153
New +$106K 0.01% 670

Other funds holding EVLV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $9.44B AUM 18.1% 1-Year Est. Return

Bayesian Capital Management's EVLV Position: Q4 2025 in Review

Bayesian Capital Management sold out of Evolv Technologies (EVLV) in Q4 2025, closing a stake of 19,700 shares — an estimated $149K sold.

Bayesian Capital Management first reported a position in EVLV in Q4 2022 and held it in 3 quarters. The position peaked at $149K in Q3 2025. 262 funds tracked by Wall St. Rank hold EVLV as of Q4 2025.

  • Bayesian Capital Management reported no remaining Evolv Technologies position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 19,700 Evolv Technologies shares in Q4 2025, an estimated $149K.
  • Bayesian Capital Management first reported a position in Evolv Technologies in Q4 2022 and held it in 3 quarters.
  • Bayesian Capital Management's Evolv Technologies position peaked at $149K in Q3 2025.
  • 262 funds tracked by Wall St. Rank held Evolv Technologies as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.